Material changes to public claims, evidence boundaries, availability, and review workflows. This is not a historical uptime log.
Capability registry and procurement boundaries
Published a machine-readable capability manifest.
Separated self-serve Starter/Analyst from Fund guided pilot and Enterprise inquiry.
Marked bulk export, live Toss checkout, production email delivery, and a publishable live report unavailable.
Added an explicit global-registry and therapeutic-coverage boundary.
Public-claim correction
Removed unqualified whole-registry record and country counts from public acquisition surfaces.
Replaced exhaustive FDA language with curated-coverage language.
Removed unsupported vendor-replacement, seat, bulk-export, priority-queue, and annual-plan claims.
Evidence and newcomer guidance
Added Global Evidence, Evidence Passport, Trust Center, source states, and non-affiliation disclosures.
Added per-session screen tutorials with a permanent replay control.
Separated evaluated, pending, and ungradable legacy predictions with a low-sample warning.
To report an incorrect claim or source state, email orion.biotech.ai@gmail.com. Include the page, current wording, primary source, and requested correction. A correction should be recorded here when it materially changes user interpretation.